Pentam and Ramelteon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pentam (pentamidine isethionate) and Ramelteon (ramelteon). Common drug interactions include abdominal pain among females and oesophagitis among males.
The phase IV clinical study analyzes what interactions people have when they take Pentam and Ramelteon. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Pentam?
Pentam has active ingredients of pentamidine isethionate. eHealthMe is studying from 5,686 Pentam users. Check the latest studies of Pentam.
What is Ramelteon?
Ramelteon has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 1,387 Ramelteon users. Check the latest studies of Ramelteon.
17 people who take Pentam and Ramelteon together, and have interactions are studied.

What are the common drug interactions of Pentam and Ramelteon, by gender? *:
female:
- Abdominal pain
- Blood lactate dehydrogenase increased
- Diarrhoea
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Renal failure (kidney dysfunction)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
male:
- Oesophagitis (inflammation of oesophagus)
- Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
- Pulmonary alveolar haemorrhage (acute bleeding)
- Skin exfoliation (removal of the oldest dead skin cells)
- Thrombocytopenia (decrease of platelets in blood)
- Anaemia (lack of blood)
- Cholecystitis acute (rapid infection of gallbladder)
- Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
- Gastrointestinal mucosal exfoliation (mucous membrane comes out and new takes place in gastrointestinal tract)
- Haematemesis (vomiting of blood)
What are the common drug interactions of Pentam and Ramelteon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Oesophagitis (inflammation of oesophagus)
- Skin exfoliation (removal of the oldest dead skin cells)
- Thrombocytopenia (decrease of platelets in blood)
- Anaemia (lack of blood)
- Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
- Gastrointestinal mucosal exfoliation (mucous membrane comes out and new takes place in gastrointestinal tract)
- Haematemesis (vomiting of blood)
- Oesophageal haemorrhage (bleeding from oesophagus)
30-39:
n/a
40-49:
- Cholecystitis acute (rapid infection of gallbladder)
- Pulmonary alveolar haemorrhage (acute bleeding)
50-59:
n/a
60+:
- Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
- Abdominal pain
- Blood lactate dehydrogenase increased
- Diarrhoea
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Renal failure (kidney dysfunction)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
What are the existing conditions these people have? *
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 23.53%
- Constipation: 3 people, 17.65%
- Venoocclusive Liver Disease (small veins in the liver are obstructed): 3 people, 17.65%
- Bone Marrow Conditioning Regimen: 2 people, 11.76%
- T-Cell Type Acute Leukaemia (a form of cancer of the white blood cells): 2 people, 11.76%
- Dry Skin: 2 people, 11.76%
- Mantle Cell Lymphoma Refractory (relapsed cancer of lymphocytes, a type of white blood cell): 2 people, 11.76%
- Mantle Cell Lymphoma Recurrent (cancer of lymphocytes, a type of white blood cell- recurrent): 2 people, 11.76%
- Erosive Oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time): 2 people, 11.76%
- Skin Infection: 2 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take Pentam and Ramelteon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Pentam and Ramelteon:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pentam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ramelteon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pentam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ramelteon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pentamidine isethionate and ramelteon (the active ingredients of Pentam and Ramelteon, respectively), and Pentam and Ramelteon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Kerlone cause Overdose? - 4 seconds ago
- Drug interactions of Humalog and Minitran - 5 seconds ago
- Drug interactions of Eliquis and Amaryl - 10 seconds ago
- Drug interactions of Revatio and Valcyte - 19 seconds ago
- Osteoporosis and Hot Flushes Aggravated - 19 seconds ago
- Could Xgeva cause Gallstones? - 23 seconds ago
- Ovarian Cancer and Oropharyngeal Pain - 24 seconds ago
- Drug interactions of Depakote Er and Potassium - 38 seconds ago
- Could Methylprednisolone cause Blood In Stool? - 40 seconds ago
- Could Adalat cause Upper Limb Fracture? - 41 seconds ago